C Diff Kills, it’s Curable, it’s Avoidable
Posted in Newest drugs on Mar 13th, 2009
There are multiple strains of C Diff floating around our hospitals and this one is pretty scary. “This NAP1 strain has a genetic change that results in literally 16 to 23 times more toxin,” says William Jarvis, MD according to an excellent recent College of American Pathologists article [1]. In the same article, L. Clifford [...]
Posted in Newest drugs on Feb 19th, 2009
It looks like “Fidaxomicin (formerly OPT-80, PAR-101 or Difimicin),” is still looking very promising so be sure to keep searching for its new name, Fidaxomicin. [1] Again, Fidaxomicin is a new drug soon to complete its last studies before applying for FDA approval. It has been shown, so far, to a tiny bit more effective [...]
Posted in Newest drugs on Nov 26th, 2008
According to TheStreet.com [1], top-line results of Optimer’s phase III Opt-80 study are demonstrating higher cure rates and lower relapse rates when compared to vancomycin.
Cure Rates Similar
If you ask me, the cure rates were similar (88% versus 86%), but this is still fantastic news. Currently, there are two antibiotics being widely used to treat C [...]